We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · January 13, 2022

Effect of Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes

Circulation

 

Additional Info

Circulation
Effect of the Glucagon-like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: a Pooled Analysis of SUSTAIN 6 and LEADER Trials
Circulation 2021 Dec 14;[EPub Ahead of Print], AM Shaman, SC Bain, GL Bakris, JB Buse, T Idorn, KW Mahaffey, JFE Mann, MA Nauck, S Rasmussen, P Rossing, B Wolthers, B Zinman, V Perkovic

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading